Noor Ul Ain Rehman
Tue, March 31, 2026 astatine 10:06 AM CDT 1 min read
In a abstracted development, Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) was downgraded to Hold from Buy by Jefferies connected March 16. The steadfast besides chopped the terms people connected the banal to $330 from $522 aft assuming sum of the name, telling investors successful a probe enactment that it is “impressed” with the company’s RNAi platform. The steadfast said that it believes the shares are “priced to perfection”, adding that Alnylam Pharmaceuticals Inc.’s (NASDAQ:ALNY) longer-term statement expectations are astatine hazard arsenic they terms successful large marketplace maturation and debased competition.
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is simply a biopharmaceutical institution that develops and commercializes caller therapeutics based connected ribonucleic acerb interference.
While we admit the imaginable of ALNY arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich successful 10 Years AND 12 Best Stocks That Will Always Grow.
Disclosure: None. Follow Insider Monkey connected Google News.

2 days ago
3





English (CA) ·
English (US) ·
Spanish (MX) ·